American Chemical Society--235th National Meeting. Part 2.
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. livia.hookes@thomsonreuters.com
Livia
L
Hookes
Mark
M
Lakeram
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D004345:Drug Industry; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D019428:HIV Integrase Inhibitors / Q000494:pharmacology; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy; D010600:Pharmacology / Q000639:trends*; D012106:Research
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D019428:HIV Integrase Inhibitors; D066246:ErbB Receptors